These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. GPR17: molecular modeling and dynamics studies of the 3-D structure and purinergic ligand binding features in comparison with P2Y receptors. Parravicini C; Ranghino G; Abbracchio MP; Fantucci P BMC Bioinformatics; 2008 Jun; 9():263. PubMed ID: 18533035 [TBL] [Abstract][Full Text] [Related]
31. A chimeric rat brain P2Y1 receptor tagged with green-fluorescent protein: high-affinity ligand recognition of adenosine diphosphates and triphosphates and selectivity identical to that of the wild-type receptor. Vöhringer C; Schäfer R; Reiser G Biochem Pharmacol; 2000 Apr; 59(7):791-800. PubMed ID: 10718337 [TBL] [Abstract][Full Text] [Related]
32. Identification of endogenous surrogate ligands for human P2Y receptors through an in silico search. Hiramoto T; Nonaka Y; Inoue K; Yamamoto T; Omatsu-Kanbe M; Matsuura H; Gohda K; Fujita N J Pharmacol Sci; 2004 May; 95(1):81-93. PubMed ID: 15153654 [TBL] [Abstract][Full Text] [Related]
33. A guanine nucleotide-independent inwardly rectifying cation permeability is associated with P2Y1 receptor expression in Xenopus oocytes. O'Grady SM; Elmquist E; Filtz TM; Nicholas RA; Harden TK J Biol Chem; 1996 Nov; 271(46):29080-7. PubMed ID: 8910562 [TBL] [Abstract][Full Text] [Related]
34. Fidelity in functional coupling of the rat P2Y1 receptor to phospholipase C. Schachter JB; Boyer JL; Li Q; Nicholas RA; Harden TK Br J Pharmacol; 1997 Nov; 122(6):1021-4. PubMed ID: 9401764 [TBL] [Abstract][Full Text] [Related]
35. Gi- and Gq-coupled ADP (P2Y) receptors act in opposition to modulate nociceptive signaling and inflammatory pain behavior. Malin SA; Molliver DC Mol Pain; 2010 Apr; 6():21. PubMed ID: 20398327 [TBL] [Abstract][Full Text] [Related]
36. Cloned and transfected P2Y4 receptors: characterization of a suramin and PPADS-insensitive response to UTP. Charlton SJ; Brown CA; Weisman GA; Turner JT; Erb L; Boarder MR Br J Pharmacol; 1996 Dec; 119(7):1301-3. PubMed ID: 8968535 [TBL] [Abstract][Full Text] [Related]
37. P2Y receptors: biological advances and therapeutic opportunities. Shaver SR Curr Opin Drug Discov Devel; 2001 Sep; 4(5):665-70. PubMed ID: 12825461 [TBL] [Abstract][Full Text] [Related]
38. Identification of 6H1 as a P2Y purinoceptor: P2Y5. Webb TE; Kaplan MG; Barnard EA Biochem Biophys Res Commun; 1996 Feb; 219(1):105-10. PubMed ID: 8619790 [TBL] [Abstract][Full Text] [Related]
39. The 6H1 orphan receptor, claimed to be the p2y5 receptor, does not mediate nucleotide-promoted second messenger responses. Li Q; Schachter JB; Harden TK; Nicholas RA Biochem Biophys Res Commun; 1997 Jul; 236(2):455-60. PubMed ID: 9240460 [TBL] [Abstract][Full Text] [Related]
40. P2Y1-receptors in human platelets which are pharmacologically distinct from P2Y(ADP)-receptors. Fagura MS; Dainty IA; McKay GD; Kirk IP; Humphries RG; Robertson MJ; Dougall IG; Leff P Br J Pharmacol; 1998 May; 124(1):157-64. PubMed ID: 9630355 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]